Foulkes WD - Search Results

1

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.

Goffin JR, Chappuis PO, Bégin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD. Goffin JR, et al. Among authors: foulkes wd. Cancer. 2003 Feb 1;97(3):527-36. doi: 10.1002/cncr.11080. Cancer. 2003. PMID: 12548593 Free article.

2

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status.

Foulkes WD, Stamp GW, Afzal S, Lalani N, McFarlane CP, Trowsdale J, Campbell IG. Foulkes WD, et al. Br J Cancer. 1995 Oct;72(4):883-8. doi: 10.1038/bjc.1995.428. Br J Cancer. 1995. PMID: 7547235 Free PMC article.

3

Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.

Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG. Bryan EJ, et al. Among authors: foulkes wd. Cancer Res. 1996 Feb 15;56(4):719-21. Cancer Res. 1996. PMID: 8631002

4

Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.

Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Foulkes WD, et al. BMJ. 1996 Sep 21;313(7059):716-21. doi: 10.1136/bmj.313.7059.716. BMJ. 1996. PMID: 8819440 Free PMC article.

5

Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study.

Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL. Foulkes WD, et al. Int J Cancer. 1995 Dec 11;63(6):769-73. doi: 10.1002/ijc.2910630603. Int J Cancer. 1995. PMID: 8847131

6

Screening for cancer in high-risk families.

Foulkes WD, Narod SA. Foulkes WD, et al. Cancer Treat Res. 1996;86:165-82. doi: 10.1007/978-1-4613-1265-9_12. Cancer Treat Res. 1996. PMID: 8886445 Review. No abstract available.

7

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.

Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE, et al. Tonin P, et al. Among authors: foulkes wd. Nat Med. 1996 Nov;2(11):1179-83. doi: 10.1038/nm1196-1179. Nat Med. 1996. PMID: 8898735 Review. No abstract available.

8

Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first-degree relatives: a case-control study.

Cutler C, Foulkes WD, Brunet JS, Flanders TY, Shibata H, Narod SA. Cutler C, et al. Among authors: foulkes wd. Melanoma Res. 1996 Dec;6(6):435-40. doi: 10.1097/00008390-199612000-00005. Melanoma Res. 1996. PMID: 9013481

9

BRCA1 mutations and survival in women with ovarian cancer.

Brunet JS, Narod SA, Tonin P, Foulkes WD. Brunet JS, et al. Among authors: foulkes wd. N Engl J Med. 1997 Apr 24;336(17):1256; author reply 1256-7. N Engl J Med. 1997. PMID: 9121524 No abstract available.

10

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Karp SE, et al. Among authors: foulkes wd. Cancer. 1997 Aug 1;80(3):435-41. doi: 10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y. Cancer. 1997. PMID: 9241077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

737 results

Search Page